GME
63
12
CL
58
2
EOG
42
-8
URI
58
-5
COST
56
3
TRV
64
2
PCAR
50
-3
ADT
32
9
BAX
30
-3
XRX
52
-3
FCX
53
-5
GPC
37
-14
NWSA
47
-2
PEP
47
-3
HIG
68
4
NI
65
2
VNO
57
-2
L
55
-4
PPL
65
6
RF
51
-2
GME
63
12
CL
58
2
EOG
42
-8
URI
58
-5
COST
56
3
TRV
64
2
PCAR
50
-3
ADT
32
9
BAX
30
-3
XRX
52
-3
FCX
53
-5
GPC
37
-14
NWSA
47
-2
PEP
47
-3
HIG
68
4
NI
65
2
VNO
57
-2
L
55
-4
PPL
65
6
RF
51
-2
Financhill
Back

Pacira BioSciences Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
33

PCRX
Pacira BioSciences

Last Price:
14.50
Seasonality Move:
-2.82%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
33
Pacira BioSciences (PCRX) is a Sell

Is Pacira BioSciences a Buy, Sell or Hold?

  • The current Pacira BioSciences [PCRX] share price is $14.52. The Score for PCRX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • PCRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

PCRX Stock Price Chart

What is Pacira BioSciences's stock price today?

  • The Pacira BioSciences share price today is $14.52
    The current trend is relatively stagnant and PCRX is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

PCRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.66 Sell
Relative Strength Index (14 RSI): 46.94 Sell
Chaikin Money Flow: -1701132 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.35 - 14.93) Buy
Bollinger Bands (100): (15.74 - 28.84) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

PCRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.81 Buy
20-day SMA: 14.24 Buy
50-day SMA: 16.6 Sell
200-day SMA: 26.16 Sell
8-day EMA: 14.17 Buy
20-day EMA: 14.41 Buy
50-day EMA: 16.86 Sell
200-day EMA: 24.76 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Pacira BioSciences Earnings Growth & PCRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.11 per share, and an increase next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Pacira BioSciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):